Ligand-specific Utilization of the Extracellular Membrane-proximal Region of the Gp130-related Signalling Receptors

Overview

Journal Biochem J

Specialty Biochemistry

Date 1999 Dec 22

PMID 10600635

Citations 10

Authors

A Hammacher

J Wijdenes

D J Hilton

N A Nicola

R J Simpson

J E Layton

Affiliations

Soon will be listed here.

Abstract

The receptor gp130 is used by the interleukin-6 (IL-6)-type cytokines, which include IL-6 and leukaemia-inhibitory factor (LIF). To investigate the role of the three extracellular membrane-proximal fibronectin-type-III-like (FNIII) modules of gp130 and the related receptor for granulocyte colony-stimulating factor (G-CSFR) in cytokine signal transduction we have transfected into murine myeloid M1-UR21 cells the chimaera (GR-FNIII)gp130, which contains the membrane-proximal FNIII modules of the G-CSFR on a gp130 backbone, and its complement, the chimaera (gp130-FNIII)GR. Whereas the binding affinities of (125)I-labelled IL-6 to (GR-FNIII)gp130, or of (125)I-Tyr1,3-G-CSF to (gp130-FNIII)GR, were similar to wild-type gp130 and wild-type G-CSFR, respectively, (125)I-LIF failed to bind with high affinity to (GR-FNIII)gp130. In assays measuring differentiation the (gp130-FNIII)GR cells were fully responsive to G-CSF, whereas the (GR-FNIII)gp130 cells responded fully to the agonistic anti-gp130 monoclonal antibody (mAb) B-S12, but not to IL-6 or LIF. Neutralizing mAbs that recognize the membrane-proximal FNIII modules of gp130 or the G-CSFR differentially interfered with signalling by B-S12, LIF and G-CSF. The data suggest that B-S12 and G-CSF induce the correct orientation or conformation for signalling by the wild-type and chimaeric homodimeric receptors, that the membrane-proximal region of gp130 is important for the correct formation of the signalling IL-6-IL-6 receptor-gp130 complex and that this region is also involved in LIF-dependent receptor heterodimerization and signalling.

Citing Articles

Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency.

Gardner S, Jin Y, Fyfe P, Voisin T, Bellon J, Pohler E Nat Commun. 2024; 15(1):2071.

PMID: 38453915 PMC: 10920896. DOI: 10.1038/s41467-024-46235-6.

Selective loss of function variants in cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function.

Shahin T, Aschenbrenner D, Cagdas D, Bal S, Conde C, Garncarz W Haematologica. 2018; 104(3):609-621.

PMID: 30309848 PMC: 6395342. DOI: 10.3324/haematol.2018.194233.

A receptor fusion protein for the inhibition of murine oncostatin M.

Brolund L, Kuster A, Korr S, Vogt M, Muller-Newen G BMC Biotechnol. 2011; 11:3.

PMID: 21223559 PMC: 3040522. DOI: 10.1186/1472-6750-11-3.

A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor.

Thompson L, Whiston R, Rakhimov Y, Taccioli C, Liu C, Croce C Cell Cycle. 2010; 9(20):4213-21.

PMID: 20962578 PMC: 3055204. DOI: 10.4161/cc.9.20.13543.

Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes.

Xu Y, Kershaw N, Luo C, Soo P, Pocock M, Czabotar P J Biol Chem. 2010; 285(28):21214-8.

PMID: 20489211 PMC: 2898449. DOI: 10.1074/jbc.C110.129502.

References

Syed R, Reid S, Li C, Cheetham J, Aoki K, Liu B . Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998; 395(6701):511-6. DOI: 10.1038/26773. View

Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park L . Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996; 271(51):32635-43. DOI: 10.1074/jbc.271.51.32635. View

Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B . Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science. 1988; 241(4867):825-8. DOI: 10.1126/science.3136546. View

Mizushima S, Nagata S . pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 1990; 18(17):5322. PMC: 332193. DOI: 10.1093/nar/18.17.5322. View

Bazan J . Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990; 87(18):6934-8. PMC: 54656. DOI: 10.1073/pnas.87.18.6934. View

Larsen A, Davis T, Curtis B, Gimpel S, Sims J, Cosman D . Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med. 1990; 172(6):1559-70. PMC: 2188748. DOI: 10.1084/jem.172.6.1559. View

Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T . Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 1990; 63(6):1149-57. DOI: 10.1016/0092-8674(90)90411-7. View

Watanabe M, Fukamachi H, Uzumaki H, Kabaya K, Tsumura H, Ishikawa M . Mutant protein of recombinant human granulocyte colony-stimulating factor for receptor binding assay. Anal Biochem. 1991; 195(1):38-44. DOI: 10.1016/0003-2697(91)90291-z. View

Fukunaga R, Pan C, Seto Y, Nagata S . Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991; 10(10):2855-65. PMC: 452996. DOI: 10.1002/j.1460-2075.1991.tb07835.x. View

10.

Cunningham B, Ultsch M, de Vos A, Mulkerrin M, Clauser K, Wells J . Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991; 254(5033):821-5. DOI: 10.1126/science.1948064. View

11.

Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H . Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett. 1992; 31(2):123-30. DOI: 10.1016/0165-2478(92)90138-e. View

12.

Gearing D, Comeau M, Friend D, Gimpel S, Thut C, McGourty J . The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992; 255(5050):1434-7. DOI: 10.1126/science.1542794. View

13.

de Vos A, Ultsch M, Kossiakoff A . Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992; 255(5042):306-12. DOI: 10.1126/science.1549776. View

14.

Hilton D, Nicola N . Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J Biol Chem. 1992; 267(15):10238-47. View

15.

Zhang J, Moritz R, Reid G, Ward L, Simpson R . Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms. Eur J Biochem. 1992; 207(3):903-13. DOI: 10.1111/j.1432-1033.1992.tb17123.x. View

16.

Fukunaga R, Wood W, Goeddel D, Nagata S . Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A. 1993; 90(1):123-7. PMC: 45612. DOI: 10.1073/pnas.90.1.123. View

17.

Davis S, Aldrich T, Stahl N, Pan L, Taga T, Kishimoto T . LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993; 260(5115):1805-8. DOI: 10.1126/science.8390097. View

18.

Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K . IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 1993; 260(5115):1808-10. DOI: 10.1126/science.8511589. View

19.

Akira S, Taga T, Kishimoto T . Interleukin-6 in biology and medicine. Adv Immunol. 1993; 54:1-78. DOI: 10.1016/s0065-2776(08)60532-5. View

20.

Lieschke G, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C . Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84(6):1737-46. View